Trial Profile
Predictive factors for response to abiraterone in metastatic castration refractory prostate cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 22 Oct 2015 New trial record